Prostate cancer, race, and socioeconomic status: Inadequate adjustment for social factors in assessing racial differences

Prostate

Volumn 29, Issue 5, 1996, Pages 271-281

  Dale, William ^a,b   Vijayakumar, Srinivasan ^c,f   Lawlor, Edward F ^a,d,e   Merrell, Katie ^e  

^a Irving B Harris Grad Sch Pub P   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d School of Social Service Admin   (United States)

^e The University of Chicago   (United States)

^f MICHAEL REESE HOSPITAL   (United States)

Author keywords

cancer; prostate; race; socioeconomic status

Indexed keywords

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK ASSESSMENT; SOCIAL STATUS;

CONTINENTAL POPULATION GROUPS; HUMANS; MALE; MEDLINE; PROSTATIC NEOPLASMS; RESEARCH DESIGN; SOCIOECONOMIC FACTORS;

EID: 0029828975     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199611)29:5<271::AID-PROS1>3.0.CO;2-D     Document Type: Article

References (53)

1. Reed WL: "Health and Medical Care of African-Americans." Westport, CT: Auburn House, 1993.
2. Mebane C, Gibbs Y, Horm J: Current status of prostate cancer in North Amican black males. J Natl Med Assoc 82:782-783, 1990.
3. Hardy RE, Hargreaves MK: Cancer prognosis in black Americans: A mini-review. J Natl Med Assoc 83:574-579, 1991.
4. Ragland KE, Selvin S, Merrill DW: Black-white differences in stage-specific cancer survival: Analysis of seven selected sites. Am J Epidemiol 133:672-682, 1991.
5. Bang KMj, White JE, Gause BI, Leffall LD: Evaluation of recent trends in cancer mortality and incidence among blacks. Cancer 61:1255-1261, 1988.
6. Fraumeni JF: The face of cancer in the United States. Hosp Pract 18:81-96, 1983.
7. Jackson MA, Kovi J, Heshmat MY, Ogunmuyiwa TA, Jones GW, Williams AO, Christian EC, Nkposong EO, Rao MS, Jackson AG, Ahluwalia BS: Characterization of prostatic carcinoma among blacks: A comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. Prostate 1:185-205, 1980.
8. Lee JY, Soong SJ: Cancer mortality in the south, 1950 to 1980. South Med J 83:185-90, 1990.
9. Guinan PD, Wiggishoff CC, Rotkin ID, et al: Prostate cancer in Illinois. Illinois Med J 166:341-45, 1984.
10. Kovi J: Carcinoma of the prostate: A disease of black men? J Natl Med Assoc 75:121-122, 1983.
11. Natarajan N, Murphy GP, Mettlin C: Prostate cancer in blacks: An update from the American College of Surgeons' patterns of care studies. J Surg Oncol 40:232-236, 1989.
12. American Cancer Society: "Cancer in the Economically Disadvantaged." A Special Report. Subcommittee on Cancer in the Econonically Disadvantaged. New York: American Cancer Society, 1986.
13. Vogelstein B: The multistep nature of cancer. Trends Genet 9(4):138-141, 1993.
14. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990.
15. Cavenee WK, Dryia TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784, 1983.
16. Bosland MC, Meulen D-V D, Sukumar S, Ofner P, Leav I, Han X, Liehr JG: Multistage prostate carcinogenesis: the role of hormones. In Harris CC, Hirohashi S, Ito N, Pilot HE, Sugimura T, Terada M, Yokota J (eds): "Multistage Carcinogenesis." Boca Raton, FL: CRC Press, 1992, pp 109-123.
17. Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT: Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25:249-265, 1994.
18. Owen W: Cancer of the prostate. A literature review. J Chron Dis 29:89-114, 1976.
19. Breslow N, Chan CW, Dhom G, Drury LM, Franks B, et al: Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20:680-688, 1977.
20. Staszewski J, Haenszel W: Cancer mortality among the Polish born in the United States. J Natl Cancer Inst 35:291-297, 1965.
21. Haenzel S, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43-68, 1968.
22. Jackson MA, Kovi J, Heshmat MY, Ogunmuyiwa TA, Jones GW, Ogunmuyiwa TA, Jones GW, Williams AO, Christian EC, Nkposong EO, Rao MS, Jackson AG, Ahluwalia BS: Characterization of prostatic carcinoma among blacks: A comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. The Prostate 1:185-205, 1980.
23. Waterouse J, Muir CS, Correa P, Powell J (eds): "Cancer Incidence in Five Continents." Vol. III. Lyon: IARC, 1976.
24. Carter BS, Carter HB, Isaacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate 16:187-197, 1990.
25. Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE: Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 78:869-874, 1987.
26. Ross RK, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B: Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76:45-48, 1986.
27. Hill P, Wynder EL, Garbaczewshi L, Garnes H, Walker ARP: Diet and urinary steroids in black and white North American men and black South African men. Cancer Res 39:5101-5105, 1979.
28. Axtell LM, Asire AJ, Myers MH (eds): "Cancer Patient Survival." Report No. 5. Department of Health, Education, and Welfare Publication (NIH) 77-992. Washington, D.C.: DHEW, 1976.
29. LaViest TA: Beyond dummy variables and sample selection: What health services researchers ought to know about race as a variable. Health Ser Res 29:1-16, 1994.
30. Lawlor E, Vijayakumar S, Merrell K, Dale W: A framework for modeling social factors in cancer effectiveness research. CHAS Working Paper #8, 1994.
31. Earnster VL, Selvin S, Sacks ST, Austin DF, Brown SM, Windelstein W: Prostatic cancer: Mortality and incidence rates by race and social class. Am J Epidemiol 107:311-320, 1978.
32. Harris JE: Social and economic causes of cancer. In Bunker JP, Gomby DS, Kehrer BH (eds): "Pathways to Health: The Role of Social Factors." Menlo Park, California: Kaiser Foundations, 1989.
33. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, Hunter CP, Herman AA, Kurman R, Blacklow R, Shapiro S, Edwards BK: Racial differences in survival from breast cancer. JAMA 272:947-954, 1994.
34. Devesa SS, Diamond EL: Association of breast cancer and cervical cancer incidences with income and education among whites and blacks. J Natl Cancer Inst 65: 515-528, 1980.
35. Dayal HH, Power RN, Chiu C: Race and socio-economic status in survival from breast cancer. J Chron Dis 35:675-683, 1982.
36. Freeman HP, Wasfie TJ: Cancer of the breast in poor black women. Cancer 63:2562-2569, 1989.
37. Morton WE, Baker HW, Fletcher WS: Geographic pathology of uterine cancers in Oregon: Risks of double primaries and effects of socioeconomic status. Gynecol Oncol 16:63-77, 1983.
38. Devesa SS, Diamond EL: Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol 118: 818-831, 1983.
39. Weston B, Grufferman S, MacMillan JP, Cohen HJ: Effects of socioeconomic and clinical factors on survival in multiple myeloma. J Clin Oncol 5:1977-1984, 1987.
40. Keirn W, Metter G: Survival of cancer patients by economic status in a free care setting. Cancer 55:1552-1555, 1985.
41. Cella DF, Orav EJ, Kornblith AB, Holland JC, Silberfarb PM, Lee KW, Comis RL, Perry M, Cooper R, Maurer LH, Hoth DF, Perloff M, Bloomfield CD, McIntyre OR, Leone L, Lesnick G, Nixxen N, Glicksman A, Henderson E, Barcos M, Crichlow R, Faulkner CS, Eaton W, North W, Schein P, Chu F, King G, Chahinian AP: Socioeconomic status and cancer survival. J Clin Oncol 9:1500-1509, 1991.
42. Berg JW, Ross R, Latourette HB: Economic status and survival of cancer patients. Cancer 39:467-477, 1977.
43. Williams RR, Horm JW: Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the Third National Cancer Survey. J Natl Cancer Inst 58(3):525-547, 1977.
44. Page WF, Kuntz AJ: Racial and socioeconomic factors in cancer survival: A comparison of Veterans Administration results with selected studies. Cancer 45:1029-1040, 1980.
45. Dayal H, Chui CY, Sharrar R, Mangan J, Rosenwalke I, Shapiro S, Henley AJ, Goldberg-Alberts R, Kinman J: Ecologie correlates of cancer mortality patterns in an industrialized urban population. J Natl Cancer Inst 73: 565-574, 1984.
46. Polednak AP: Cancer mortality in a higher-income black population in New York state: Comparison with rates in the United States as a whole. Cancer 66:1654-1660, 1990.
47. McWhorter WP, Schatzkin AG, Horm JW, Brown CC: Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 63:982-987, 1989.
48. Baquet CR, Horm JW, Gibbs T, Greenwald P: Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 83:551-557, 1991.
49. Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP: Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 39:284-292, 1979.
50. Dayal HH, Chui C: Factors associated with racial differences in survival for prostatic carcinoma. J Chron Dis 35:553-560, 1982.
51. Dayal HH, Polissar L, Dahlberg S: Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J Natl Cancer Inst 74:1001-1006, 1985.
52. Yu H, Harris RE, Wynder EL: Case-control study of prostate cancer and socioeconomic factors. Prostate 13: 317-325, 1988.
53. Vijayakumar S, Karrison T, Weichselbaum RR, Chan S, Quadri SF, Awan A: Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biol Prev 1:541-545, 1992.